Overview of Centers for Disease Control and Prevention's Case Investigation of Cervical Cancer Study.
Vicki B Benard, April Greek, J Elizabeth Jackson, Virginia Senkomago, Mei-Chin Hsieh, Amanda Crosbie, Georgetta Alverson, Antoinette M Stroup, Lisa C Richardson, Cheryll C Thomas
Author Information
Vicki B Benard: 1Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
April Greek: 2Battelle, Seattle, Washington.
J Elizabeth Jackson: 2Battelle, Seattle, Washington.
Virginia Senkomago: 1Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mei-Chin Hsieh: 3Louisiana Tumor Registry and Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana.
Amanda Crosbie: 4New Jersey Department of Health, Cancer Epidemiology Services, Trenton, New Jersey.
Georgetta Alverson: 5Michigan Cancer Surveillance Program, Lansing, Michigan.
Antoinette M Stroup: 6Rutgers School of Public Health, Piscataway, New Jersey.
Lisa C Richardson: 1Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Cheryll C Thomas: 1Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Despite advances in Cervical Cancer screening, a significant number of women in the United States have not received adequate screening. Studies have suggested that approximately half of the women who developed Cervical Cancer were not adequately screened. The Centers for Disease Control and Prevention (CDC) Case Investigation of Cervical Cancer (CICC) Study took a unique approach to reconstruct the time before a woman's Cervical Cancer diagnosis and understand the facilitators and barriers to screening and care. This article provides an overview of the study. This study included all Cervical Cancer survivors diagnosed with invasive Cervical Cancer aged 21 years and older in three U.S. states from 2014-2016. The study design consisted of three different data collection methods, including comprehensive registry data, a mailed survey, and medical chart abstraction. This overview compares the characteristics of Cervical Cancer survivors in the three states by study participation and eligibility status. Registries identified 2,748 women diagnosed with invasive Cervical Cancer. Of these, 1,730 participants were eligible for participation, 28% ( = 481) enrolled in the study and 23% ( = 400) consented to the medical chart abstraction. The CICC Study is unique in that it addresses, with medical record verification, the medical history of woman 5 years before their Cervical Cancer diagnosis as well as provides information from the woman on her health care behaviors. This study provides data on a general population of Cervical Cancer survivors in three states that could be used to guide interventions to increase Cervical Cancer screening.
